Betadine maker Win-Medicare eyes $150-200 million stake sale; taps EY

March 5, 2026

The Umesh Modi Group has reportedly sought a valuation of up to ₹4,000 crore for the pharmaceutical firm as it looks to offload a minority stake to private equity investors.
#Betadine #maker #WinMedicare #eyes #million #stake #sale #taps

Trichy Sankaran displays the fine art of accompaniment at Sandeep Narayan’s concert

Rupee rebounds from lowest level to settle 45 paise higher at 91.60 against U.S. dollar

Betadine maker Win-Medicare eyes $150-200 million stake sale; taps EY

LEAVE A REPLY Cancel reply

Latest Articles

‘South Africa found calm in the storm…’: Sachin hails Proteas maiden WTC title win

OpenAI and Nvidia’s circular deals are emblematic of a speculative bubble—A repeat of the dot-com era in the making?

L&T secures major orders for building & factories business in Bengaluru and Mumbai

Maharashtra Minister Nitesh Rane labels Kerala as ‘mini Pakistan’; later says, ‘If treatment meted out to Hindus…’

Refining margins would have been higher had contamination incident not happened: HPCL CMD

Musician Job Kurian on his latest release, ‘Nizhal’, and his two-decades-long journey in the industry

Who is Vibha Devi, Bihar MLA with ₹31 crore net worth, goes viral with her oath-reading video | Watch

Thiruvananthapuram-based couple launches Badi Rasam, a ready-to-eat meal pack for ₹49

Rahul Matthan: Data-rich insurance models could fail beyond a point

The Trump family’s next venture is a mobile phone company